Back to the Drawing Board for HHS Guidance on Rx Discounts

Bloomberg BNA reported on the Trump administration’s decision to withdraw the proposed mega-guidance and send it back to The U.S. Department of Health and Human Services. The guidance must now be resubmitted to the White House Office of Management and Budget in order to advance.